AVAX Technologies Company
Avax Technologies, Inc is a Philadelphia based biotechnology company whose most advanced product candidate is MVax for melanoma.
Technology:
Whole-Cell Antigens
Industry:
Whole-Cell Antigens
Headquarters:
Philadelphia, Pennsylvania, United States
Founded Date:
1990-01-01
Employees Number:
1-10
Funding Status:
IPO
Register and Claim Ownership